PTAB designates seven IPR decisions as “informative”

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

PTAB designates seven IPR decisions as “informative”

ptab-web-icon.jpg

The Patent Trial and Appeal Board has designated seven of its decisions rendered in inter partes review (IPR) proceedings as “informative”

uspto.jpg

In each decision, the PTAB denied institution of an IPR under 35 USC § 325(d), which permits the Director to take into account whether, and reject the petition or request because, the same or substantially the same prior art or arguments previously were presented.

The seven decisions are:

Medtronic, Inc v Nuvasive Inc., Paper 8, No. IPR2014-00487 (September 11 2014)

Unified Patents Inc v PersonalWeb Techs., LLC, Paper 13, No. IPR2014-00702 (July 24 2014)

Prism Pharma Co v Choongwae Pharma Corp., Paper 14, No. IPR2014-00315 (July 8 2014)

Unilever, Inc v Procter & Gamble Co., Paper 17, No. IPR2014-00506 (July 7 2014)

Medtronic, Inc v Robert Bosch Healthcare Systems, Inc., Paper 17, No. IPR2014-00436 (June 19 2014)

Intelligent Bio-Systems Inc. v Illumina Cambridge Limited, Paper 19, No. IPR2013-00324 (November 21 2013)

ZTE Corp v ContentGuard Holdings, Inc., Paper 12, No. IPR2013-00454 (25 September 25 2013)

Decisions designated as "informative" can be viewed here.


more from across site and SHARED ros bottom lb

More from across our site

Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Mike Rueckheim reunites with 12 of his former Winston & Strawn colleagues as King & Spalding continues aggressive hiring streak
As global commerce continues to expand through e-commerce platforms and digital marketplaces, protecting brands has become a growing challenge for organisations worldwide. Counterfeiting, intellectual property infringement, and online brand abuse are increasing across industries, making brand protection strategies a critical priority for businesses.
Henrik Holzapfel and Chuck Larsen of McDermott Will & Schulte explain why a Court of Appeal ruling could promote access to justice and present a growth opportunity for litigation finance
A co-partner in charge says the UK prosecution teams are a ‘vital’ part of the firm’s offering, while praising a key injunction win
Gift this article